Services for Investors
Most venture funds have a company portfolio with a wide range of technologies. Considering the fast development of new technologies and therapeutic approaches, it is sometimes difficult to have sufficient in-house expertise for a proper evaluation of potential investment candidates.
We have a comprehensive experience in the scientific and commercial evaluation of new business ideas and through our long-term professional experience we are used to look at both sides of the story, i.e. from the investors point of view and from big pharma.